152 related articles for article (PubMed ID: 6304480)
1. Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma.
Hunsmann G; Pedersen NC; Theilen GH; Bayer H
Med Microbiol Immunol; 1983; 171(4):233-41. PubMed ID: 6304480
[TBL] [Abstract][Full Text] [Related]
2. Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective.
Pedersen NC; Johnson L; Birch D; Theilen GH
Vet Immunol Immunopathol; 1986 Feb; 11(2):123-48. PubMed ID: 3008409
[TBL] [Abstract][Full Text] [Related]
3. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
4. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
[TBL] [Abstract][Full Text] [Related]
5. Feline cytotoxic immune mechanisms against virus-associated leukemia and fibrosarcoma.
McCarty JM; Grant CK
Cell Immunol; 1983 Oct; 81(1):157-68. PubMed ID: 6311439
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
[TBL] [Abstract][Full Text] [Related]
7. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
[TBL] [Abstract][Full Text] [Related]
8. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine.
Pedersen NC
J Vet Intern Med; 1993; 7(1):34-9. PubMed ID: 8384261
[TBL] [Abstract][Full Text] [Related]
10. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
[TBL] [Abstract][Full Text] [Related]
11. Leukemia specific antigens: FOCMA and immune surveillance.
Essex M; Grant CK; Cotter SM; Sliski AH; Hardy WD
Haematol Blood Transfus; 1979; 23():453-86. PubMed ID: 232469
[TBL] [Abstract][Full Text] [Related]
12. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
[TBL] [Abstract][Full Text] [Related]
13. Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein.
Stephenson JR; Essex M; Hino S; Hardy WD; Aaronson SA
Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1219-23. PubMed ID: 191832
[TBL] [Abstract][Full Text] [Related]
14. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
Lutz H; Pedersen NC; Theilen GH
Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection.
Lehmann R; Joller H; Haagmans BL; Lutz H
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):61-9. PubMed ID: 1337403
[TBL] [Abstract][Full Text] [Related]
16. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
Chen AP; Essex ME
Cancer Invest; 1984; 2(2):81-90. PubMed ID: 6329486
[TBL] [Abstract][Full Text] [Related]
17. Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat.
Salerno RA; Lehman ED; Larson VM; Hilleman MR
J Natl Cancer Inst; 1978 Dec; 61(6):1487-93. PubMed ID: 214605
[No Abstract] [Full Text] [Related]
18. Feline leukemia vaccine: efficacy, contents and probable mechanism.
Mastro JM; Lewis MG; Mathes LE; Sharpee R; Tarr MJ; Olsen RG
Vet Immunol Immunopathol; 1986 Mar; 11(3):205-13. PubMed ID: 3008410
[TBL] [Abstract][Full Text] [Related]
19. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.
Langhammer S; Hübner J; Kurth R; Denner J
Immunology; 2006 Feb; 117(2):229-37. PubMed ID: 16423059
[TBL] [Abstract][Full Text] [Related]
20. Development and testing of an inactivated feline leukemia virus vaccine.
Hoover EA; Mullins JI; Chu HJ; Wasmoen TL
Semin Vet Med Surg Small Anim; 1995 Nov; 10(4):238-43. PubMed ID: 8820598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
